New technology to combat eye diseases

University of Liverpool has worked with PolyPhotonix, an SME developing organic lighting products and technologies, to create a product that can halt the decline of patients who have diabetic retinopathy or age-related macular degeneration.

The revolutionary treatment is Noctura 400, a non-invasive device that looks like a sleep mask. It projects light onto the eyes while the user is asleep. This protects the eye from oxygen starvation, which can lead to blindness.

The product is now sold commercially as part of monitored therapy in the UK, parts of Europe and internationally. It is currently undergoing clinical trials and there is interest from the NHS. Diabetes costs the NHS over £10 billion each year (around 10% of the total healthcare budget) and the cost of treating eye disease is around £4 billion.

Related case studies

Queen Mary University London - Supporting cutting edge life science businesses

The Queen Mary BioEnterprises Innovation Centre is helping life science businesses across the capital turn their ideas into real-world applications such as vaccines and anti-viral treatments.

Read more >

Reducing blood transfusions to lower patient risk, reduce costs and save lives

More than half a million people in the UK receive a blood transfusion each year and demand is increasing. Our ageing population, and a stringent donor selection process, mean the supply of blood is limited. 40% fewer new donors came forward last year compared with a decade ago. Recognising these challenges, researchers at the University of Edinburgh have shown the benefits of reducing the use of blood transfusions in intensive care and surgery.

Read more >